Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis

Area of Science:

• Gastroenterology
• Molecular Biology
• Oncology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease impacting the gastrointestinal tract.
• Prolonged UC inflammation elevates the risk of colorectal cancer (CRC).
• MicroRNAs (miRNAs) are implicated as key mediators linking inflammation and cancer development.

Purpose of the Study:

• To investigate site-specific miRNA expression differences in colon biopsies from Northern Indian UC patients.
• To identify specific miRNAs associated with distinct colonic regions (Rectosigmoid vs. Ascending Colon) in UC.
• To explore the potential role of differential miRNA expression in UC-associated CRC development.

Main Methods:

• Collection of colon biopsy samples from UC patients and healthy controls from Rectosigmoid (RS) and Ascending Colon (AC) areas.
• Comparison of miRNA expression between RS and AC using microarray analysis.
• Validation of differential miRNA expression using quantitative Real-Time PCR (qRT-PCR).
• Analysis of demographic and pathological data for UC-associated CRC patient tumor site assessment.

Main Results:

• Six miRNAs (hsa-miR-146b-5p, hsa-miR-335-3p, hsa-miR-342-3p, hsa-miR-644b-3p, hsa-miR-491-3p, hsa-miR-4732-3p) were significantly downregulated in the RS compared to AC in UC patients.
• One miRNA, hsa-miR-141-3p, was upregulated in the RS compared to AC in UC patients.
• Hospital database analysis indicated that CRC in UC patients predominantly occurred in the rectosigmoid region.

Conclusions:

• This study is the first to report differential miRNA expression across distinct colonic sites in UC patients.
• The findings suggest that site-specific miRNA dysregulation in UC may contribute to the higher incidence of CRC in the rectosigmoid area.
• Differential miRNA expression is proposed as a potential mechanism in the pathogenesis of UC-associated colorectal cancer.